Retatrutide
£80.00
Discover the cutting-edge innovation with Retatrutide (LY3437943), an investigational peptide drug developed by Eli Lilly, now available at Peptidex. This triple agonist is designed to target the GLP-1 receptor (glucagon-like peptide-1), GIP receptor (glucose-dependent insulinotropic polypeptide), and Glucagon receptor, offering promising advancements in metabolic regulation research. At Peptidex, we are committed to providing top-tier research compounds and exemplary customer service to support your scientific endeavors. Trust us to deliver quality and reliability as you explore the potential of Retatrutide (LY3437943) in your studies. Elevate your research with Peptidex today.
Quantity
Disclaimer
The product referenced on this page, including any reference to Tirzepatide, is provided strictly for laboratory research purposes only. It is not a drug, food, cosmetic, or dietary supplement, and is not intended for human.
This product is not for self-administration and must not be used to diagnose, treat, prevent, or cure any disease or medical condition. Any descriptions or references to biological mechanisms are provided solely for scientific education and informational purposes.
The product is a compounded research material and is not FDA-approved. It has not been reviewed for safety, efficacy, or purity for any purpose beyond controlled research settings. Sale and distribution of this product is restricted to qualified professionals and institutional laboratories only.
By accessing this site or purchasing this product, you confirm that:
-
You are a licensed researcher or institution authorised to handle chemical substances
-
You understand and accept all risks associated with handling experimental research compounds
-
You will use the product only in lawful laboratory conditions and in full compliance with applicable local, national, or international regulations
⚠️ Not for human consumption. Not for medical or therapeutic use. Not intended for individuals with a Body Mass Index (BMI) under 30 unless under appropriate clinical supervision.
Use of this product outside of its intended research application is a violation of our Terms of Sale and may be prohibited by law.
